問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
China Medical University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Division of Rheumatology
下載
2017-02-24 - 2018-12-31
Condition/Disease
-
Test Drug
Participate Sites4Sites
Terminated3Sites
未分科
2018-05-01 - 2021-06-30
Recruiting3Sites
2023-12-26 - 2026-05-14
Participate Sites6Sites
Not yet recruiting5Sites
Recruiting1Sites
2021-06-01 - 2026-06-30
Participate Sites10Sites
Recruiting10Sites
2023-07-01 - 2024-12-17
Recruiting6Sites
2015-09-01 - 2018-12-31
Participate Sites3Sites
2021-06-30 - 2024-09-02
Participate Sites5Sites
Recruiting5Sites
2021-03-01 - 2027-04-01
Participate Sites1Sites
2018-11-01 - 2021-12-31
Lupus Nephritis
Orelvo (voclosporin)
Terminated2Sites
2015-08-01 - 2017-07-31
rheumatoid arthritis (RA) who had an inadequate response to DMARDs
ASP015K
Participate Sites11Sites
Terminated10Sites
全部
